quinoxalines has been researched along with Bile Duct Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleary, JM; Hirner, J; LeBoeuf, N; Murphy, G; Sheets, A | 1 |
| Bossaer, JB; Weaver, A | 1 |
| Javle, M; King, G | 1 |
| Alpini, G; Francis, H; Glaser, S; Kanno, N; Lesage, G; Phinizy, JL | 1 |
2 review(s) available for quinoxalines and Bile Duct Cancer
| Article | Year |
|---|---|
Fibroblast growth factor receptor (FGFR) inhibitors: A review of a novel therapeutic class.
Topics: Bile Duct Neoplasms; Carcinoma, Transitional Cell; Cholangiocarcinoma; Clinical Trials as Topic; Humans; Morpholines; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; Pyrroles; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 3 | 2021 |
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma.
Topics: Aniline Compounds; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Clinical Trials as Topic; Humans; Morpholines; Mutation; Phenylurea Compounds; Precision Medicine; Pyrazoles; Pyrimidines; Pyrroles; Quinazolines; Quinoxalines; Receptors, Fibroblast Growth Factor; Signal Transduction | 2021 |
2 other study(ies) available for quinoxalines and Bile Duct Cancer
| Article | Year |
|---|---|
Fibroblast Growth Factor Receptor Inhibitors and Nonuremic Calciphylaxis.
Topics: Aged; Bile Duct Neoplasms; Biopsy; Calciphylaxis; Cholangiocarcinoma; Female; Humans; Pyrazoles; Quinoxalines; Receptor, Fibroblast Growth Factor, Type 2; Skin; Thigh | 2021 |
Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities.
Topics: Adrenergic alpha-Agonists; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Brimonidine Tartrate; Cell Division; Cholangiocarcinoma; Cyclic AMP; Humans; Inositol 1,4,5-Trisphosphate; MAP Kinase Signaling System; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Quinoxalines; ras Proteins; Receptors, Adrenergic, alpha-2; Tumor Cells, Cultured | 2002 |